成人患者利奈唑胺群体药代动力学模型的外部验证
房秋 , 蒋双妙 , 王晶 , 罗雪梅 , 金路 , 朱怀军
中国临床药理学与治疗学 ›› 2026, Vol. 31 ›› Issue (10) : 1363 -1376.
成人患者利奈唑胺群体药代动力学模型的外部验证
External validation of population pharmacokinetic models for linezolid in adult patients
目的: 评估已发表利奈唑胺群体药代动力学模型的预测性能,探索模型的适用性与局限性。方法: 系统检索 PubMed、中国知网等数据库(建库至 2025 年 6 月),提取模型信息;收集南京鼓楼医院 111 例成人感染患者的 223 个稳态血药浓度数据,通过拟合优度、预测误差检验及可视化预测检验进行外部验证。结果: 本研究共纳入 25 个利奈唑胺群体药代动力学模型,验证显示:群体预测表现欠佳,最优模型 R2 仅 0.28,预测误差在±30%(F30)范围内均低于 35%,所有模型均未达到既定标准;个体预测能力较好,最优模型 R2 达 0.92,IF30 值最高 82.11%,大部分模型展现出良好的预测能力;亚组分析提示,特定临床环境可改善群体预测,高精度个体预测模型稳定性强。结论: 现有的利奈唑胺群体药代动力学模型在本中心患者中预测误差大、外推能力有限,临床适用性不足;个体预测有助于提高模型预测的准确性。未来需纳入更多协变量、扩大特殊人群样本,通过前瞻性研究增强模型泛化能力。
AIM: To evaluate the predictive performance of published population pharmacokinetic models for linezolid and explore their applicability and limitations. METHODS: A systematic search was conducted in databases such as PubMed and CNKI (up to June 2025), and model information was extracted. Steady-state blood concentration data from 223 samples of 111 adult infected patients at Nanjing Drum Tower Hospital were collected for external validation using goodness-of-fit tests, prediction error tests, and visual predictive checks. RESULTS: A total of 25 population pharmacokinetic models for linezolid were included in this study. Validation results showed that the population prediction performance was suboptimal, with the best model having an R2 of only 0.28. The prediction error within the ±30% range (F30) was below 35%, and none of the models met the established standards. However, individual prediction capability was relatively good, with the best model achieving an R2 of 0.92 and an IF30 value as high as 82.11%, indicating that most models demonstrated good prediction ability. Subgroup analysis suggested that specific clinical environments could improve population predictions, and high-precision individual prediction models showed strong stability. CONCLUSION: The existing population pharmacokinetic models for linezolid exhibit large prediction errors and limited extrapolation ability in patients at this center, with insufficient clinical applicability. Individual predictions can help improve model accuracy. Future research should incorporate more covariates, expand the sample size of special populations, and enhance model generalizability through prospective studies.
| [1] |
|
| [2] |
邢贞建, 李祥, 江慧贤, |
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
张雷. 利奈唑胺在中国人群的群体药代/药效动力学研究[D].北京: 解放军医学院, 2011. |
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
Bock M, Theut AM, Van Hasselt JGC, |
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
林忠, 谢群莉, 戴淑萍, |
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
肖莹, 张弋, 李淑娟, |
| [44] |
|
| [45] |
|
| [46] |
|
江苏省青年医学人才资助项目(QNRC2016013)
江苏省 333 高层次人才培养计划([2024]3-2409)
南京大学中国医院改革发展研究院课题项目(NDYGN2023027)
/
| 〈 |
|
〉 |